You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 歐康維視生物-B(1477.HK)漲4.27% 2021年營收大增328.73%
格隆匯 03-28 10:07

格隆匯3月28日丨歐康維視生物-B(1477.HK)漲4.27%,報10.02港元,總市值66億港元。該公司3月25日盤後發佈公吿,截至2021年12月31日止年度,公司收益為人民幣5614.6萬元,同比增長328.73%;年內虧損為人民幣2.60億元,去年同期則虧損為22.65億元,基本每股虧損為人民幣0.43分。 公吿稱,收益增加乃主要歸因於(i)眼科產品(即歐沁®、酒石酸溴莫尼定滴眼液、OT-401及康姝)的銷售額大幅增加,主要是由於公司在醫院營銷及推廣該等產品的工作進展順利;及(ii)有關埃美丁®及貝特舒®的以銷售為基礎的特許權使用費收入增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account